Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 50,754 | 70,582 | 51,217 | 62,922 | 56,352 |
| Cost of Goods | 9,943 | 9,415 | 9,076 | 10,142 | 9,371 |
| Gross Profit | 40,811 | 61,167 | 42,141 | 52,780 | 46,981 |
| Operating Expenses | 53,885 | 54,453 | 56,468 | 61,587 | 61,800 |
| Operating Income | -12,131 | 7,129 | -14,251 | -8,665 | -14,448 |
| Interest Expense | 3,627 | 3,784 | 3,068 | 3,076 | 3,052 |
| Other Income | -15,705 | 50 | 386 | 595 | 615 |
| Pre-tax Income | -31,463 | 3,395 | -16,933 | -11,146 | -16,885 |
| Net Income Continuous | -31,463 | 3,395 | -16,933 | -11,199 | -16,885 |
| Net Income | $-31,463 | $3,395 | $-16,933 | $-11,199 | $-16,885 |
| EPS Basic Total Ops | -0.79 | 0.09 | -0.43 | -0.28 | -0.44 |
| EPS Basic Continuous Ops | -0.79 | 0.09 | -0.43 | -0.29 | -0.43 |
| EPS Diluted Total Ops | -0.79 | 0.08 | -0.43 | -0.28 | -0.44 |
| EPS Diluted Continuous Ops | -0.79 | 0.08 | -0.43 | -0.29 | -0.43 |
| EBITDA(a) | $-9,199 | $9,366 | $-12,335 | $-6,766 | $-12,505 |